about
sameAs
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclidesEvaluation of a Proposed Biodegradable 188Re Source for Brachytherapy Application: A Review of Dosimetric ParametersIsothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate CancerRadioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.Superparamagnetic iron oxide nanoparticles stabilized by a poly(amidoamine)-rhenium complex as potential theranostic probe.Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy.Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate.Coordination ability of trans-cyclohexane-1,2-diamine-N,N,N',N'-tetrakis(methylenephosphonic acid) towards lanthanide(III) ions.Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data.Rapid cross-linking of elastin-like polypeptides with (hydroxymethyl)phosphines in aqueous solution.Encapsulation of a radiolabeled cluster inside a fullerene cage, (177)Lu(x)Lu((3-x))N@C(80): an interleukin-13-conjugated radiolabeled metallofullerene platform.Development of a highly selective cell-permeable ratiometric fluorescent chemosensor for oxorhenium(V) ion.Synthesis of a DOTA--biotin conjugate for radionuclide chelation via Cu-free click chemistry.(175)Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals.Lower ligand denticity leading to improved thermodynamic and kinetic stability of the Gd3+ complex: the strange case of OBETA.Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Crystal structure of bromido-fac-tricarbon-yl[5-phenyl-3-(pyridin-2-yl)-1H-1,2,4-triazole-κ(2) N,N']rhenium(I)In situ cross-linking of elastin-like polypeptide block copolymers for tissue repairMolecular imaging of gene expression and protein function in vivo with PET and SPECT.Oligopyrrole macrocycles: receptors and chemosensors for potentially hazardous materials.Synthesis and pharmacology of halogenated δ-opioid-selective [d-Ala(2)]deltorphin II peptide analoguesA limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and TheranosticsSelective perrhenate recognition in pure water by halogen bonding and hydrogen bonding alpha-cyclodextrin based receptors.Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.Kinetic and high-pressure mechanistic investigation of the aqua substitution in the trans-aquaoxotetracyano complexes of re(v) and tc(v): some implications for nuclear medicine.111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging.Equilibrium and formation/dissociation kinetics of some Ln(III)PCTA complexes.New dicoumarol sodium compound: crystal structure, theoretical study and tumoricidal activity against osteoblast cancer cells.Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease.Unconventional nuclides for radiopharmaceuticalsMetastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptideTowards new functional nanostructures for medical imaging.Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy.IMPROVED SYNTHESIS OF 10-(2-ALKYLAMINO-2-OXOETHYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETIC ACID DERIVATIVES BEARING ACID-SENSITIVE LINKERS.Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.Bisphosphonates as radionuclide carriers for imaging or systemic therapy.
P2860
Q24649091-815A61C3-1950-4784-B603-6CC1F779793EQ26800232-E949D42F-D074-4C59-8EBD-F22FCD6D9933Q28821362-82EAEF46-8960-46ED-A0F4-C2A1582F0D36Q30660860-32E775AB-A1E8-4143-A6B3-312575AD10CEQ30685707-2C3AEA2C-C5F4-40C9-AE95-0A1352498F73Q30963856-C48F534E-1CE5-433B-91D0-A424F591F599Q30981846-6D5F06F9-5AC6-468D-BAA8-BD788E8CBE3BQ31060438-3973733B-E6D8-4F9B-B604-2FDF5052CC7DQ31116849-CA3897E1-E730-4735-A022-AA72BC152DCEQ33281249-905E044D-E24E-4DA8-9821-72D043167A68Q33871781-0F0216F8-5E8A-451A-8F7D-6E145631D2C1Q34039938-6C44223C-CBAC-4F16-A17A-BD401A6D506CQ34112403-D60DA1D9-ADFD-495D-922C-E1E664775FC7Q34147038-68C24311-1745-4060-868F-BCD51250BA72Q34276804-0996455B-6619-4EF5-9136-B065E651E290Q34460892-134E958B-8BBF-4D43-8ACE-1601EE301C4DQ34638812-408674A8-8195-435E-840B-B35BC2595C6DQ34788160-C27312A8-D743-43F6-BEEF-06216DFA1F88Q34918519-CE8D47C1-06AF-4D46-B457-7500E3772CFEQ35097638-DDD77D01-6EA3-4A99-92F0-1F5E59858125Q35756505-99BAD89A-ED16-4B78-9E8D-E65A9A0FF454Q35831439-ABE419FA-9049-420A-B376-8C3E68277ED1Q36296105-7D56137C-94DB-4E5E-B0F3-A7660B979D1AQ36314328-59D84A1A-5D1C-4C71-9DD8-DCF6F861C7ECQ36348748-F177FAFB-5FAC-4292-B943-9AD3803D1AA0Q36632981-E691D7F0-C0D6-46C9-A77B-B3B7BB88B589Q36743097-3B0BD26B-1D25-405A-BD4B-05B4DCD2F847Q37002963-9488ECA0-EED6-40E7-890A-231844025674Q37027906-0EAD3702-C98D-4018-8043-0B17949D9CE0Q37049634-8623E4E7-8245-4DA4-90F8-2363E9A76AF5Q37109589-0323F64A-6C1F-4C02-B25E-B308911D4F3CQ37112963-F1DF73E3-9841-43CE-B421-1D18B9318194Q37129181-6F834743-2B37-4B4C-8BC5-D89F248EAFA9Q37199680-644EA66C-9037-4A2A-B3CF-2F6575B4E0BBQ37314094-786A32F5-EAC1-4679-98BD-E9DC78B1D81AQ37342239-C066B494-2B72-428C-94F9-B2619F2FA3CEQ37400982-7E3CADEA-E416-4887-BB7F-747C5A3AB949Q37588304-779E5162-1491-4F5A-A944-5E34FDB64530Q37850696-95CC772D-9F93-4D06-B641-58706BA7FFD7Q37924117-4EF34EC3-7FB6-4053-A090-BA8C20FD7E34
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Therapeutic radiopharmaceuticals
@ast
Therapeutic radiopharmaceuticals
@en
Therapeutic radiopharmaceuticals
@nl
type
label
Therapeutic radiopharmaceuticals
@ast
Therapeutic radiopharmaceuticals
@en
Therapeutic radiopharmaceuticals
@nl
prefLabel
Therapeutic radiopharmaceuticals
@ast
Therapeutic radiopharmaceuticals
@en
Therapeutic radiopharmaceuticals
@nl
P3181
P356
P1433
P1476
Therapeutic radiopharmaceuticals
@en
P2093
T J Hoffman
W A Volkert
P304
P3181
P356
10.1021/CR9804386
P407
P577
1999-09-08T00:00:00Z